119836-12-3

Basic information

• Product Name: 4-Chlorophenyl-4-hydroxypiperidine
• Synonyms: 4-chloro-1-phenyl-4-piperidinol;1-(4-Chlorophenyl)piperidin-4-ol
• CAS NO: 119836-12-3
• Molecular Formula: C₁₁H₁₄ClNO
• Molecular Weight: 211.691
• Mol File: 119836-12-3.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Chlorophenyl-4-hydroxypiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chlorophenyl-4-hydroxypiperidine(119836-12-3)
• EPA Substance Registry System: 4-Chlorophenyl-4-hydroxypiperidine(119836-12-3)

Safety Data

• Hazardous Substances Data: 119836-12-3(Hazardous Substances Data)

Usage

General Description

4-Chlorophenyl-4-hydroxypiperidine, also known as 4-CPM, is a chemical compound that belongs to the piperidine class. It is a psychoactive drug and a designer drug that acts as a potent and selective serotonin reuptake inhibitor. It is a derivative of piperidine and is structurally related to other psychedelics like 4-fluoromethcathinone and 4-methylphenethylamine. 4-CPM is known for its hallucinogenic effects and has been linked to several cases of overdose and adverse health effects. It is considered a controlled substance and its use is prohibited in many countries.

Upstream product

• 3592-25-4 1,5-dichloropentan-3-one 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 637-87-6 1-Chloro-4-iodobenzene 
• 106-39-8 bromochlorobenzene 
• 827605-29-8 2-(4-chloro-phenyl)-5,5-dimethyl-[1,3,2]dioxaborinane 
• 1380288-25-4 4-hydroxypiperidin-1-yl benzoate 
• 142752-12-3 4-(4-hydroxypiperidin-1-yl)aniline 
• 72548-31-3 1,5-Dichloropentan-3-ol 
• 106-47-8 4-chloro-aniline 

Downstream Products

• 1054635-91-4 2'-O-[1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl]-2-N-phenylacetyl-3',5'-O-(1,1,3,3-tetraisopropyldisiloxyl)guanosine 
• 908140-97-6 N-(9-{(2R,3R,3aR,9aR)-3-[1-(4-Chloro-phenyl)-4-ethoxy-piperidin-4-yloxy]-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl}-9H-purin-6-yl)-2,2-dimethyl-propionamide 
• 908140-96-5 N-(1-{(2R,3R,3aR,9aR)-3-[1-(4-Chloro-phenyl)-4-ethoxy-piperidin-4-yloxy]-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl}-2-oxo-1,2-dihydro-pyrimidin-4-yl)-benzamide 
• 263009-03-6 2'-O-[1-(4-Chlorophenyl)-4-ethoxypiperidin-4-yl]-2-N-(phenylacetyl)guanosine 
• 908140-95-4 1-{(2R,3R,3aR,9aR)-3-[1-(4-Chloro-phenyl)-4-ethoxy-piperidin-4-yloxy]-5,5,7,7-tetraisopropyl-tetrahydro-1,4,6,8-tetraoxa-5,7-disila-cyclopentacycloocten-2-yl}-1H-pyrimidine-2,4-dione 
• 263008-98-6 2'-O-[1-(4-Chlorophenyl)-4-ethoxypiperidin-4-yl]-6-N-pivaloyladenosine 
• 263009-01-4 4-N-Benzoyl-2'-O-[1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl]cytidine 
• 263009-04-7 2'-O-[1-(4-Chlorophenyl)-4-ethoxypiperidin-4-yl]guanosine 
• 263009-02-5 2'-O-[1-(4-Chlorophenyl)-4-ethoxypiperidin-4-yl]cytidine 
• 263008-94-2 2'-O-[1-(4-Chlorophenyl)-4-ethoxypiperidin-4-yl]uridine 
• 263008-84-0 2'-O-[1-(4-Chlorophenyl)-4-methoxypiperidin-4-yl]uridine 
• 263008-89-5 1-(4-Chlorophenyl)-4,4-diethoxypiperidine 
• 263008-90-8 1-(4-Chlorophenyl)-4-ethoxy-1,2,5,6-tetrahydropyridine 
• 115012-53-8 1-(4-Chlorophenyl)-4-methoxy-1,2,5,6-tetrahydropyridine 

Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE

Disclosed herein are dihydroceramide desaturase 1 (Des1) inhibitor compounds and compositions, which are useful in the treatment of diseases, such as metabolic disorders, where inhibition of Des1 is expected to be therapeutic to a patient. Methods of inhibition of Des1 activity in a human or animal subject are also provided.

Synthesis of hindered anilines: Copper-catalyzed electrophilic amination of aryl boronic esters

No longer a hindrance: Copper-catalyzed electrophilic amination of aryl boronic esters is accomplished under mild reaction conditions using 2.5-5.0 mol % of a catalyst derived from copper tert-butoxide and Xantphos ligand (see scheme). The reaction tolerates a wide range of functional groups and can be used to prepare some of the most hindered anilines made to date. Copyright